Hydroxyprogesterone Caproate Production Cost Reports

The report provides a detailed analysis essential for establishing a Hydroxyprogesterone Caproate production plant. It encompasses all critical aspects necessary for Hydroxyprogesterone Caproate production, including the cost of Hydroxyprogesterone Caproate production, Hydroxyprogesterone Caproate plant cost, Hydroxyprogesterone Caproate production costs, and the overall Hydroxyprogesterone Caproate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Hydroxyprogesterone Caproate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Hydroxyprogesterone Caproate is a synthetic progestin hormone that has been most commonly used in healthcare settings. It is widely used for the prevention of spontaneous preterm births in singleton pregnancies in women who have previously had a spontaneous preterm birth. It works by helping the uterus stay relaxed and reducing the chances of early contractions. It also finds its application in the treatment of certain menstrual disorders and hormone imbalances where additional progesterone support is needed. It is mainly used to help prevent premature birth in pregnant women who have had a history of early labour by supporting hormone levels during pregnancy. In some cases, it is included in hormone therapy for specific types of cancer, like endometrial or breast cancer.

The market for Hydroxyprogesterone Caproate is primarily driven by its application as a prescription drug for managing certain pregnancy-related conditions, which fuels its demand in the pharmaceutical industry. Its administration for reducing the risk of recurrent spontaneous preterm birth in women with a history of preterm delivery in singleton pregnancies largely boosts its demand in the medical sector. Its usage as a as an intramuscular injection to help reduce the risk of early labour in specific high-risk pregnancies further strengthens its demand in the medical and healthcare sectors. Its demand in medical research to help study progesterone activity and develop improved therapeutic options related to reproductive health also contributes to its market expansion.

Its involvement in hormone replacement therapy and treatment of menstrual disorders further contributes to its rising demand in the pharmaceutical and healthcare industries. The increasing awareness around maternal health and the growing focus on reducing pregnancy-related complications have largely promoted its demand in prenatal care. Additionally, industrial Hydroxyprogesterone Caproate procurement is influenced by factors such as the cost and availability of raw materials, strict regulatory approvals, and adherence to pharmaceutical-grade production standards. Advancements in formulation technologies, supplier credibility, quality certifications, and efficient supply chain management also impact its global procurement practices.

Raw Material for Hydroxyprogesterone Caproate Production

According to the Hydroxyprogesterone Caproate production plant project report, the major raw materials for Hydroxyprogesterone Caproate production include 17α-oxypregnene-3-acetate, p-Toluenesulfonic Acid, and Caproic Acid Anhydride.

Production Process of Hydroxyprogesterone Caproate

The extensive Hydroxyprogesterone Caproate production cost report consists of the following industrial production process:

1. Production via Esterification Reaction: The production process of Hydroxyprogesterone caproate begins with 17α-oxypregnene-3-acetate, which is reacted with p-toluenesulfonic acid and caproic acid anhydride under a nitrogen atmosphere, which facilitates esterification at the C17 position. After completion, excess anhydride is removed with steam in the presence of pyridine, and the resulting residue is extracted and crystallised to give 17α-oxypregnenolone-3-acetate-17-caproate. Then, this intermediate is partially saponified by acid reflux in methanol to remove the acetate group, which forms 17α-oxypregnenolone-17-caproate. Finally, this compound undergoes oxidation by using aluminium isopropylate in cyclohexanone and toluene, followed by crystallisation results in the formation of pure hydroxyprogesterone caproate as the final product.

Hydroxyprogesterone caproate is a synthetic ester of 17α-hydroxyprogesterone and caproic acid, used primarily as a long-acting progestin. It exists in the form of a white to off-white crystalline powder. It is generally odourless. The molecular formula of the compound is C27H40O4, and its molar mass is around 428.56 g/mol. The compound has a density of about 1.09 g/cm³. It is practically insoluble in water but is soluble in organic solvents such as chloroform, ethanol, acetone, and vegetable oils. The melting point of hydroxyprogesterone caproate is in the range of 119-121 degree Celsius, and its boiling point is around 463.43 degree Celsius. The compound contains ester and ketone functional groups, which contribute to its lipophilic nature and prolonged biological activity. It should be used according to the prescription because it can cause some side effects, including injection site reactions (pain, swelling, pruritus, nodule), nausea, diarrhoea, urticaria, and pruritus.